Profile picture

Professor Stephane Heymans

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
Membership: FESC Member HFA Member
Follow
Biography
Cardiologist and Research Scientist since 2003 focusing on the molecular mechanisms of heart failure, looking at the interplay between inflammatory cells, fibroblasts and cardiomyocytes. Unraveled the key role of structural and non-structural matrix proteins and RNAs, including microRNAs, matrix metalloproteinases, collagens and matri-cellular proteins, in mediating cardiac inflammation, fibrosis and dysfunction. His heart failure research focuses on heart with preserved ejection fraction (HFPEF) and dilated cardiomyopathies (DCM) (www.hfresearch.eu)SH is acknowledged for developing a clinical care program and related cohorts of non-ischemic CMP, myocarditis and HFPEF patients at the MUMC (> 1400 patients cohort and biobank of HFPEF and DCM patients with > 12 yrs FU). His program brings together immunologists, microbiologists, geneticians and molecular cardiologists to study the role of genetics, viruses, inflammation and other environmental factors in cardiomyopathies.
Logo ESC

Contributor content

Inflammation in heart failure
Session
Inflammation in heart failure
19 May 2025
The hidden burden of COVID-19 in cardiovascular patients: It's time for a rethink
Session
The hidden burden of COVID-19 in cardiovascular patients: It's time for a rethink
18 May 2025
Myofilaments in heart failure
Session
Myofilaments in heart failure
21 January 2025
COVID-19 and cardiovascular disease: rising to the challenge
Session
COVID-19 and cardiovascular disease: rising to the challenge
1 September 2024
Gene editing and gene therapies to cure cardiovascular diseases
Session
Gene editing and gene therapies to cure cardiovascular diseases
31 August 2024
Next generation heart failure therapies
Session
Next generation heart failure therapies
11 May 2024
Valvular disease and myocardial remodelling: a dangerous liaison
Session
Valvular disease and myocardial remodelling: a dangerous liaison
28 August 2023
Current knowledge about COVID-19 myopericarditis: what have we learned?
Session
Current knowledge about COVID-19 myopericarditis: what have we learned?
27 August 2023
Myocardial disease 1
Session
Myocardial disease 1
22 May 2023
Cardiomyopathies: what’s new?
Session
Cardiomyopathies: what’s new?
22 May 2023

ESC 365 is supported by